CHRS

Biotechnology CHRS Uncategorized

Coherus BioSciences Q4 2025 Earnings Preview

Mar 8, 2026

Biotechnology CHRS Uncategorized

Coherus Oncology prices stock offering to raise $50.1M

Feb 13, 2026

Biotechnology CHRS JNJ Uncategorized

Coherus, J&J agree to evaluate combination prostate cancer treatment

Feb 4, 2026

ALXO Biotechnology CHRS CLYM CTNM EKSO FHLC FTRE FXH GRAL IHI IPSC IRWD IXJ IYH PEPG Uncategorized VHT XLV

Cheap high flyer healthcare stocks – high momentum and low valuation

Feb 2, 2026

Biotechnology CHRS Uncategorized

Coherus Oncology a new outperform at Oppenheimer on tagmokitug potential

Jan 23, 2026